Diagnosis and therapy of multiple myeloma
Antonio Palumbo, Chiara Cerrato
Korean J Intern Med. 2013;28(3):263-273. Published online 2013 May 1 DOI: https://doi.org/10.3904/kjim.2013.28.3.263
Citations to this article as recorded by 
What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma
Bruno Almeida Costa, Tarek H. Mouhieddine, Joshua Richter
Targeted Oncology.2022; 17(4): 383. CrossRef
Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation
Sai-Ling Hu, Min Liu, Jun-Yu Zhang
World Journal of Clinical Cases.2022; 10(32): 11712. CrossRef
Frequentist and Bayesian meta‐regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data
Anthony J. Hatswell, Darren Burns, Gianluca Baio, Frances Wadelin
Health Economics.2019; 28(5): 653. CrossRef
Effects of stress appraisal on the quality of life of adult patients with multiple myeloma and their primary family caregivers in Korea
In Seo La, Eun Kyoung Yun
Psycho-Oncology.2017; 26(10): 1640. CrossRef
Comparison of cyclophosphamide–thalidomide–dexamethasone to bortezomib–cyclophosphamide–dexamethasone as induction therapy for multiple myeloma patients in Brazil
Suelen Vigolo, Joice Zuckermann, Rosane Isabel Bittencourt, Lúcia Silla, Diogo André Pilger
Hematology/Oncology and Stem Cell Therapy.2017; 10(3): 135. CrossRef
New Treatment Methods in Multiple Myeloma
Szende Jakab, Erzsébet Lázár, István Benedek, Judit Beáta Köpeczi, Annamária Pakucs, István Benedek
Journal of Interdisciplinary Medicine.2017; 2(2): 144. CrossRef
Concomitant multiple myeloma spectrum diagnosis in a central retinal vein occlusion: a case report and review
Christopher J Borgman
Clinical and Experimental Optometry.2016; 99(4): 309. CrossRef
The Prognostic Significance of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios in Patients With Multiple Myeloma
Supakanya Wongrakpanich, Gemlyn George, Wikrom Chaiwatcharayut, Sylvia Biso, Nellowe Candelario, Varun Mittal, Sherry Pomerantz, Gabor Varadi
Journal of Clinical Laboratory Analysis.2016; 30(6): 1208. CrossRef
Optimal maintenance and consolidation therapy for multiple myeloma in actual clinical practice
Ho Sup Lee, Chang-Ki Min
The Korean Journal of Internal Medicine.2016; 31(5): 809. CrossRef
A Case of Light Chain Deposition Disease in a Patient with Diabetes and Nodular Glomerulosclerosis
Kyung Ho Lee, Soo Hoon Kang, Hyun Woo Lee, Ga Eun Park, Yun Soo Hong, Jung Eun Lee, Yoon Goo Kim
Korean Journal of Medicine.2015; 88(3): 318. CrossRef
New Approaches to Management of Multiple Myeloma
Sonja Genadieva-Stavric, Federica Cavallo, Antonio Palumbo
Current Treatment Options in Oncology.2014; 15(2): 157. CrossRef
Pomalidomide for the treatment of relapsed and refractory multiple myeloma
Anna Guidetti, Claudia Paba Prada, Jacob P Laubach, Cindy Varga, Michelle E Maglio, Mary McKenney, Deborah Doss, Robert L Schlossman, Constantine Mitsiades, Teru Hideshima, Güllü T Görgün, Irene M Ghobrial, Noopur Raje, Nikhil Munshi, Kenneth C Anderson,
Expert Opinion on Orphan Drugs.2014; 2(10): 1089. CrossRef
Characteristics and Results of the Treatment of Multiple Myeloma in the Subject under the Age of 65 at the University Hospital of Yopougon in Abidjan, Côte d’Ivoire
Diebkilé Aïssata Tolo, Duni Sawadogo, Danho Clotaire Nanho, Boidy Kouakou, N’Dogomo Méité, Roméo Ayémou, Paul Kouéhion, Mozart Konan, Yassongui Mamadou Sékongo, Emeraude N’Dhatz, Ismaël Kamara, Alexis Silué, Kouassi Gustave Koffi, Ibrahima Sanogo
Advances in Hematology.2013; 2013: 1. CrossRef